Fight Bladder Cancer (Trading) Ltd - Period Ending 2018-03-31

Fight Bladder Cancer (Trading) Ltd - Period Ending 2018-03-31


Fight Bladder Cancer (Trading) Ltd 09988853 false 2017-04-01 2018-03-31 2018-03-31 The principal activity of the company is that of a book shop and cafe. Digita Accounts Production Advanced 6.21.8540.0 Software true true 09988853 2017-04-01 2018-03-31 09988853 2018-03-31 09988853 bus:OrdinaryShareClass1 bus:CumulativeShares 2018-03-31 09988853 core:RetainedEarningsAccumulatedLosses 2018-03-31 09988853 core:ShareCapital 2018-03-31 09988853 core:CurrentFinancialInstruments 2018-03-31 09988853 core:CurrentFinancialInstruments core:WithinOneYear 2018-03-31 09988853 core:FurnitureFittings 2018-03-31 09988853 core:OfficeEquipment 2018-03-31 09988853 bus:SmallEntities 2017-04-01 2018-03-31 09988853 bus:AuditExemptWithAccountantsReport 2017-04-01 2018-03-31 09988853 bus:FullAccounts 2017-04-01 2018-03-31 09988853 bus:SmallCompaniesRegimeForAccounts 2017-04-01 2018-03-31 09988853 bus:RegisteredOffice 2017-04-01 2018-03-31 09988853 bus:Director1 2017-04-01 2018-03-31 09988853 bus:Director3 2017-04-01 2018-03-31 09988853 bus:Director4 2017-04-01 2018-03-31 09988853 bus:OrdinaryShareClass1 bus:CumulativeShares 2017-04-01 2018-03-31 09988853 bus:PrivateLimitedCompanyLtd 2017-04-01 2018-03-31 09988853 core:FurnitureFittings 2017-04-01 2018-03-31 09988853 core:OfficeEquipment 2017-04-01 2018-03-31 09988853 core:OtherRelatedParties 2017-04-01 2018-03-31 09988853 countries:UnitedKingdom 2017-04-01 2018-03-31 09988853 2017-03-31 09988853 core:FurnitureFittings 2017-03-31 09988853 core:OfficeEquipment 2017-03-31 09988853 2016-02-04 2017-03-31 09988853 2017-03-31 09988853 bus:OrdinaryShareClass1 bus:CumulativeShares 2017-03-31 09988853 core:RetainedEarningsAccumulatedLosses 2017-03-31 09988853 core:ShareCapital 2017-03-31 09988853 core:CurrentFinancialInstruments 2017-03-31 09988853 core:CurrentFinancialInstruments core:WithinOneYear 2017-03-31 09988853 core:FurnitureFittings 2017-03-31 09988853 core:OfficeEquipment 2017-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 09988853

Fight Bladder Cancer (Trading) Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2018

KRW Accountants Ltd
The Mill
Pury Hill Business Park
Alderton Road
Towcester
NN12 7LS

 

Fight Bladder Cancer (Trading) Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Financial Statements

4 to 7

 

Fight Bladder Cancer (Trading) Ltd

Company Information

Directors

Mr A Winterbottom

Mr J L Hester

Mr C J Jackson

Registered office

36 Station Road
Chinnor
Oxfordshire
OX39 4QH

Accountants

KRW Accountants Ltd
The Mill
Pury Hill Business Park
Alderton Road
Towcester
NN12 7LS

 

Fight Bladder Cancer (Trading) Ltd

(Registration number: 09988853)
Balance Sheet as at 31 March 2018

Note

2018
£

2017
£

Fixed assets

 

Tangible assets

4

32,566

48,848

Current assets

 

Stocks

5

2,500

2,750

Debtors

6

-

1

Cash at bank and in hand

 

1,229

818

 

3,729

3,569

Creditors: Amounts falling due within one year

7

(106,486)

(86,798)

Net current liabilities

 

(102,757)

(83,229)

Net liabilities

 

(70,191)

(34,381)

Capital and reserves

 

Called up share capital

1

1

Profit and loss account

(70,192)

(34,382)

Total equity

 

(70,191)

(34,381)

For the financial year ending 31 March 2018 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

 

Fight Bladder Cancer (Trading) Ltd

(Registration number: 09988853)
Balance Sheet as at 31 March 2018

Approved and authorised by the Board on 20 November 2018 and signed on its behalf by:
 

.........................................

Mr A Winterbottom
Director

 

Fight Bladder Cancer (Trading) Ltd

Notes to the Financial Statements for the Year Ended 31 March 2018

1

General information

The company registration number is 09988853

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
36 Station Road
Chinnor
Oxfordshire
OX39 4QH

These financial statements were authorised for issue by the Board on 20 November 2018.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis as the directors have agreed to support the company.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Fight Bladder Cancer (Trading) Ltd

Notes to the Financial Statements for the Year Ended 31 March 2018

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

25% straight line basis

Fixtures and fittings

25% straight line basis

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. The company subsequently considers the recoverable value of the trade debtors. When assessing impairment of trade debtors, management considers factors including the current credit rating of the debtor, the ageing profile of debtors and historical experience.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

Fight Bladder Cancer (Trading) Ltd

Notes to the Financial Statements for the Year Ended 31 March 2018

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 22 (2017 - 17).

4

Tangible assets

Fixtures and fittings
£

Office equipment
£

Total
£

Cost or valuation

At 1 April 2017

62,682

2,449

65,131

At 31 March 2018

62,682

2,449

65,131

Depreciation

At 1 April 2017

15,671

612

16,283

Charge for the year

15,670

612

16,282

At 31 March 2018

31,341

1,224

32,565

Carrying amount

At 31 March 2018

31,341

1,225

32,566

At 31 March 2017

47,011

1,837

48,848

5

Stocks

2018
£

2017
£

Other inventories

2,500

2,750

6

Debtors

2018
£

2017
£

Other debtors

-

1

-

1

 

Fight Bladder Cancer (Trading) Ltd

Notes to the Financial Statements for the Year Ended 31 March 2018

7

Creditors

Creditors: amounts falling due within one year

Note

2018
£

2017
£

Due within one year

 

Trade creditors

 

-

373

Amounts owed to group undertakings and undertakings in which the company has a participating interest

9

101,522

83,285

Taxation and social security

 

4,398

2,462

Accruals and deferred income

 

588

1,031

Other creditors

 

(22)

(353)

 

106,486

86,798

8

Share capital

Allotted, called up and fully paid shares

 

2018

2017

 

No.

£

No.

£

Ordinary of £1 each

1

1

1

1

         

9

Related party transactions

Summary of transactions with other related parties

Associated charity
 Included in other creditors is a loan from Fight Bladder Cancer, a charity based in the UK. The amount oustanding at the year end is £101,522 (2017: £83,285). The loan is interest free and has no fixed date for repayment.